检索结果 - Michel Weïwer

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Oversulfated Chondroitin Sulfate: Impact of a Heparin Impurity, Associated with Adverse Clinical Events, on Low-Molecular-Weight Heparin Preparation

    Oversulfated Chondroitin Sulfate: Impact of a Heparin Impurity, Associated with Adverse Clinical Events, on Low-Molecular-Weight Heparin Preparation 由 Zhenqing Zhang, Michel Weïwer, Boyangzi Li, Melissa M. Kemp, Tyler Daman, Robert J. Linhardt

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Chemoenzymatic Design of Heparan Sulfate Oligosaccharides*

    Chemoenzymatic Design of Heparan Sulfate Oligosaccharides* 由 Renpeng Liu, Yongmei Xu, Miao Chen, Michel Weïwer, Xianxuan Zhou, Arlene S. Bridges, Paul L. DeAngelis, Qisheng Zhang, Robert J. Linhardt, Jian Liu

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Development of small-molecule probes that selectively kill cells induced to express mutant RAS

    Development of small-molecule probes that selectively kill cells induced to express mutant RAS 由 Michel Weïwer, Joshua A. Bittker, Timothy A. Lewis, Kaoru Shimada, Wan Seok Yang, Lawrence MacPherson, Sivaraman Dandapani, Michelle Palmer, Brent R. Stockwell, Stuart L. Schreiber, Benito Muñoz

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells

    A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells 由 Michel Weïwer, James Spoonamore, Jingqiang Wei, Boris Guichard, Nathan T. Ross, Kristina Masson, Whitney Silkworth, Sivaraman Dandapani, Michelle Palmer, Christina Scherer, Andrew M. Stern, Stuart L. Schreiber, Benito Muñoz

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers

    Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers 由 Florence F. Wagner, Yarong Zhang, Daniel M. Fass, Naima T. Joseph, Jennifer Gale, Michel Weïwer, Patrick McCarren, Stewart L. Fisher, Taner Kaya, Wen‐Ning Zhao, Surya A. Reis, Krista M. Hennig, Melvin E. Thomas, Bérénice C. Lemercier, Michael C. Lewis, Ji‐Song Guan, M. P. Moyer, Edward M. Scolnick, Stephen J. Haggarty, Li‐Huei Tsai, Edward B. Holson

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia

    Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia 由 Florence F. Wagner, Lina Benajiba, Arthur J. Campbell, Michel Weïwer, Joshua R. Sacher, Jennifer Gale, Linda S. Ross, Alexandre Puissant, Gabriela Alexe, Amy Saur Conway, Morgan Back, Yana Pikman, Ilene Galinsky, Daniel J. DeAngelo, Richard M. Stone, Taner Kaya, Xi Shi, Matthew B. Robers, Thomas Machleidt, Jennifer Wilkinson, Olivier Hermine, Andrew L. Kung, Adam J. Stein, L. Damodharan, Michael T. Hemann, Edward M. Scolnick, Yanling Zhang, Jen Q. Pan, Kimberly Stegmaier, Edward B. Holson

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria

    Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria 由 Richard W. Heidebrecht, Carol A. Mulrooney, Christopher P. Austin, Robert H. Barker, Jennifer A. Beaudoin, Ken Cheng, Eamon Comer, Sivaraman Dandapani, Justin Dick, Jeremy R. Duvall, Eric H. Ekland, David A. Fidock, Mark E. Fitzgerald, Michael A. Foley, Rajarshi Guha, Paul Hinkson, Martin Kramer, Amanda K. Lukens, Daniela Masi, Lisa A. Marcaurelle, Xin‐zhuan Su, Craig J. Thomas, Michel Weïwer, Roger C. Wiegand, Dyann F. Wirth, Menghang Xia, Jing Yuan, Jinghua Zhao, Michelle Palmer, Benito Muñoz, Stuart L. Schreiber

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: